Global EPO Biomarkers Market Research Report 2023

Report ID: 1991653 | Published Date: Jan 2025 | No. of Page: 91 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global EPO Biomarkers Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Erythropoietin alfa
        1.2.3 Erythropoietin beta
        1.2.4 Erythropoietin zeta
        1.2.5 Erythropoietin theta
        1.2.6 Recombinant human erythropoietin
        1.2.7 Darbepoietin alfa
    1.3 Market by Application
        1.3.1 Global EPO Biomarkers Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Diagnostic centers
        1.3.3 Ambulatory care and surgical centers
        1.3.4 Hospitals
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global EPO Biomarkers Market Perspective (2017-2028)
    2.2 EPO Biomarkers Growth Trends by Region
        2.2.1 EPO Biomarkers Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 EPO Biomarkers Historic Market Size by Region (2017-2022)
        2.2.3 EPO Biomarkers Forecasted Market Size by Region (2023-2028)
    2.3 EPO Biomarkers Market Dynamics
        2.3.1 EPO Biomarkers Industry Trends
        2.3.2 EPO Biomarkers Market Drivers
        2.3.3 EPO Biomarkers Market Challenges
        2.3.4 EPO Biomarkers Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top EPO Biomarkers Players by Revenue
        3.1.1 Global Top EPO Biomarkers Players by Revenue (2017-2022)
        3.1.2 Global EPO Biomarkers Revenue Market Share by Players (2017-2022)
    3.2 Global EPO Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by EPO Biomarkers Revenue
    3.4 Global EPO Biomarkers Market Concentration Ratio
        3.4.1 Global EPO Biomarkers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by EPO Biomarkers Revenue in 2021
    3.5 EPO Biomarkers Key Players Head office and Area Served
    3.6 Key Players EPO Biomarkers Product Solution and Service
    3.7 Date of Enter into EPO Biomarkers Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 EPO Biomarkers Breakdown Data by Type
    4.1 Global EPO Biomarkers Historic Market Size by Type (2017-2022)
    4.2 Global EPO Biomarkers Forecasted Market Size by Type (2023-2028)
5 EPO Biomarkers Breakdown Data by Application
    5.1 Global EPO Biomarkers Historic Market Size by Application (2017-2022)
    5.2 Global EPO Biomarkers Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America EPO Biomarkers Market Size (2017-2028)
    6.2 North America EPO Biomarkers Market Size by Country (2017-2022)
    6.3 North America EPO Biomarkers Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe EPO Biomarkers Market Size (2017-2028)
    7.2 Europe EPO Biomarkers Market Size by Country (2017-2022)
    7.3 Europe EPO Biomarkers Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific EPO Biomarkers Market Size (2017-2028)
    8.2 Asia-Pacific EPO Biomarkers Market Size by Country (2017-2022)
    8.3 Asia-Pacific EPO Biomarkers Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America EPO Biomarkers Market Size (2017-2028)
    9.2 Latin America EPO Biomarkers Market Size by Country (2017-2022)
    9.3 Latin America EPO Biomarkers Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa EPO Biomarkers Market Size (2017-2028)
    10.2 Middle East & Africa EPO Biomarkers Market Size by Country (2017-2022)
    10.3 Middle East & Africa EPO Biomarkers Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Siemens
        11.1.1 Siemens Company Detail
        11.1.2 Siemens Business Overview
        11.1.3 Siemens EPO Biomarkers Introduction
        11.1.4 Siemens Revenue in EPO Biomarkers Business (2017-2022)
        11.1.5 Siemens Recent Development
    11.2 Thermo Fisher Scientific
        11.2.1 Thermo Fisher Scientific Company Detail
        11.2.2 Thermo Fisher Scientific Business Overview
        11.2.3 Thermo Fisher Scientific EPO Biomarkers Introduction
        11.2.4 Thermo Fisher Scientific Revenue in EPO Biomarkers Business (2017-2022)
        11.2.5 Thermo Fisher Scientific Recent Development
    11.3 Pfizer
        11.3.1 Pfizer Company Detail
        11.3.2 Pfizer Business Overview
        11.3.3 Pfizer EPO Biomarkers Introduction
        11.3.4 Pfizer Revenue in EPO Biomarkers Business (2017-2022)
        11.3.5 Pfizer Recent Development
    11.4 Novartis
        11.4.1 Novartis Company Detail
        11.4.2 Novartis Business Overview
        11.4.3 Novartis EPO Biomarkers Introduction
        11.4.4 Novartis Revenue in EPO Biomarkers Business (2017-2022)
        11.4.5 Novartis Recent Development
    11.5 Johnson & Johnson
        11.5.1 Johnson & Johnson Company Detail
        11.5.2 Johnson & Johnson Business Overview
        11.5.3 Johnson & Johnson EPO Biomarkers Introduction
        11.5.4 Johnson & Johnson Revenue in EPO Biomarkers Business (2017-2022)
        11.5.5 Johnson & Johnson Recent Development
    11.6 Merck
        11.6.1 Merck Company Detail
        11.6.2 Merck Business Overview
        11.6.3 Merck EPO Biomarkers Introduction
        11.6.4 Merck Revenue in EPO Biomarkers Business (2017-2022)
        11.6.5 Merck Recent Development
    11.7 LG Life Sciences India
        11.7.1 LG Life Sciences India Company Detail
        11.7.2 LG Life Sciences India Business Overview
        11.7.3 LG Life Sciences India EPO Biomarkers Introduction
        11.7.4 LG Life Sciences India Revenue in EPO Biomarkers Business (2017-2022)
        11.7.5 LG Life Sciences India Recent Development
    11.8 Amgen
        11.8.1 Amgen Company Detail
        11.8.2 Amgen Business Overview
        11.8.3 Amgen EPO Biomarkers Introduction
        11.8.4 Amgen Revenue in EPO Biomarkers Business (2017-2022)
        11.8.5 Amgen Recent Development
    11.9 Roche
        11.9.1 Roche Company Detail
        11.9.2 Roche Business Overview
        11.9.3 Roche EPO Biomarkers Introduction
        11.9.4 Roche Revenue in EPO Biomarkers Business (2017-2022)
        11.9.5 Roche Recent Development
    11.10 Agilent
        11.10.1 Agilent Company Detail
        11.10.2 Agilent Business Overview
        11.10.3 Agilent EPO Biomarkers Introduction
        11.10.4 Agilent Revenue in EPO Biomarkers Business (2017-2022)
        11.10.5 Agilent Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global EPO Biomarkers Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Erythropoietin alfa
    Table 3. Key Players of Erythropoietin beta
    Table 4. Key Players of Erythropoietin zeta
    Table 5. Key Players of Erythropoietin theta
    Table 6. Key Players of Recombinant human erythropoietin
    Table 7. Key Players of Darbepoietin alfa
    Table 8. Global EPO Biomarkers Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global EPO Biomarkers Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global EPO Biomarkers Market Size by Region (2017-2022) & (US$ Million)
    Table 11. Global EPO Biomarkers Market Share by Region (2017-2022)
    Table 12. Global EPO Biomarkers Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 13. Global EPO Biomarkers Market Share by Region (2023-2028)
    Table 14. EPO Biomarkers Market Trends
    Table 15. EPO Biomarkers Market Drivers
    Table 16. EPO Biomarkers Market Challenges
    Table 17. EPO Biomarkers Market Restraints
    Table 18. Global EPO Biomarkers Revenue by Players (2017-2022) & (US$ Million)
    Table 19. Global EPO Biomarkers Market Share by Players (2017-2022)
    Table 20. Global Top EPO Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in EPO Biomarkers as of 2021)
    Table 21. Ranking of Global Top EPO Biomarkers Companies by Revenue (US$ Million) in 2021
    Table 22. Global 5 Largest Players Market Share by EPO Biomarkers Revenue (CR5 and HHI) & (2017-2022)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players EPO Biomarkers Product Solution and Service
    Table 25. Date of Enter into EPO Biomarkers Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global EPO Biomarkers Market Size by Type (2017-2022) & (US$ Million)
    Table 28. Global EPO Biomarkers Revenue Market Share by Type (2017-2022)
    Table 29. Global EPO Biomarkers Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 30. Global EPO Biomarkers Revenue Market Share by Type (2023-2028)
    Table 31. Global EPO Biomarkers Market Size by Application (2017-2022) & (US$ Million)
    Table 32. Global EPO Biomarkers Revenue Market Share by Application (2017-2022)
    Table 33. Global EPO Biomarkers Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 34. Global EPO Biomarkers Revenue Market Share by Application (2023-2028)
    Table 35. North America EPO Biomarkers Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America EPO Biomarkers Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe EPO Biomarkers Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Europe EPO Biomarkers Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Asia-Pacific EPO Biomarkers Market Size by Region (2017-2022) & (US$ Million)
    Table 40. Asia-Pacific EPO Biomarkers Market Size by Region (2023-2028) & (US$ Million)
    Table 41. Latin America EPO Biomarkers Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Latin America EPO Biomarkers Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Middle East & Africa EPO Biomarkers Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Middle East & Africa EPO Biomarkers Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Siemens Company Detail
    Table 46. Siemens Business Overview
    Table 47. Siemens EPO Biomarkers Product
    Table 48. Siemens Revenue in EPO Biomarkers Business (2017-2022) & (US$ Million)
    Table 49. Siemens Recent Development
    Table 50. Thermo Fisher Scientific Company Detail
    Table 51. Thermo Fisher Scientific Business Overview
    Table 52. Thermo Fisher Scientific EPO Biomarkers Product
    Table 53. Thermo Fisher Scientific Revenue in EPO Biomarkers Business (2017-2022) & (US$ Million)
    Table 54. Thermo Fisher Scientific Recent Development
    Table 55. Pfizer Company Detail
    Table 56. Pfizer Business Overview
    Table 57. Pfizer EPO Biomarkers Product
    Table 58. Pfizer Revenue in EPO Biomarkers Business (2017-2022) & (US$ Million)
    Table 59. Pfizer Recent Development
    Table 60. Novartis Company Detail
    Table 61. Novartis Business Overview
    Table 62. Novartis EPO Biomarkers Product
    Table 63. Novartis Revenue in EPO Biomarkers Business (2017-2022) & (US$ Million)
    Table 64. Novartis Recent Development
    Table 65. Johnson & Johnson Company Detail
    Table 66. Johnson & Johnson Business Overview
    Table 67. Johnson & Johnson EPO Biomarkers Product
    Table 68. Johnson & Johnson Revenue in EPO Biomarkers Business (2017-2022) & (US$ Million)
    Table 69. Johnson & Johnson Recent Development
    Table 70. Merck Company Detail
    Table 71. Merck Business Overview
    Table 72. Merck EPO Biomarkers Product
    Table 73. Merck Revenue in EPO Biomarkers Business (2017-2022) & (US$ Million)
    Table 74. Merck Recent Development
    Table 75. LG Life Sciences India Company Detail
    Table 76. LG Life Sciences India Business Overview
    Table 77. LG Life Sciences India EPO Biomarkers Product
    Table 78. LG Life Sciences India Revenue in EPO Biomarkers Business (2017-2022) & (US$ Million)
    Table 79. LG Life Sciences India Recent Development
    Table 80. Amgen Company Detail
    Table 81. Amgen Business Overview
    Table 82. Amgen EPO Biomarkers Product
    Table 83. Amgen Revenue in EPO Biomarkers Business (2017-2022) & (US$ Million)
    Table 84. Amgen Recent Development
    Table 85. Roche Company Detail
    Table 86. Roche Business Overview
    Table 87. Roche EPO Biomarkers Product
    Table 88. Roche Revenue in EPO Biomarkers Business (2017-2022) & (US$ Million)
    Table 89. Roche Recent Development
    Table 90. Agilent Company Detail
    Table 91. Agilent Business Overview
    Table 92. Agilent EPO Biomarkers Product
    Table 93. Agilent Revenue in EPO Biomarkers Business (2017-2022) & (US$ Million)
    Table 94. Agilent Recent Development
    Table 95. Research Programs/Design for This Report
    Table 96. Key Data Information from Secondary Sources
    Table 97. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global EPO Biomarkers Market Share by Type: 2021 VS 2028
    Figure 2. Erythropoietin alfa Features
    Figure 3. Erythropoietin beta Features
    Figure 4. Erythropoietin zeta Features
    Figure 5. Erythropoietin theta Features
    Figure 6. Recombinant human erythropoietin Features
    Figure 7. Darbepoietin alfa Features
    Figure 8. Global EPO Biomarkers Market Share by Application in 2021 & 2028
    Figure 9. Diagnostic centers Case Studies
    Figure 10. Ambulatory care and surgical centers Case Studies
    Figure 11. Hospitals Case Studies
    Figure 12. EPO Biomarkers Report Years Considered
    Figure 13. Global EPO Biomarkers Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global EPO Biomarkers Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global EPO Biomarkers Market Share by Region: 2021 VS 2028
    Figure 16. Global EPO Biomarkers Market Share by Players in 2021
    Figure 17. Global Top EPO Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in EPO Biomarkers as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by EPO Biomarkers Revenue in 2021
    Figure 19. North America EPO Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. North America EPO Biomarkers Market Share by Country (2017-2028)
    Figure 21. United States EPO Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada EPO Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe EPO Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe EPO Biomarkers Market Share by Country (2017-2028)
    Figure 25. Germany EPO Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France EPO Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. EPO Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy EPO Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia EPO Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries EPO Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific EPO Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific EPO Biomarkers Market Share by Region (2017-2028)
    Figure 33. China EPO Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Japan EPO Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. South Korea EPO Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Southeast Asia EPO Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. India EPO Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Australia EPO Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America EPO Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America EPO Biomarkers Market Share by Country (2017-2028)
    Figure 41. Mexico EPO Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Brazil EPO Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa EPO Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa EPO Biomarkers Market Share by Country (2017-2028)
    Figure 45. Turkey EPO Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Saudi Arabia EPO Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Siemens Revenue Growth Rate in EPO Biomarkers Business (2017-2022)
    Figure 48. Thermo Fisher Scientific Revenue Growth Rate in EPO Biomarkers Business (2017-2022)
    Figure 49. Pfizer Revenue Growth Rate in EPO Biomarkers Business (2017-2022)
    Figure 50. Novartis Revenue Growth Rate in EPO Biomarkers Business (2017-2022)
    Figure 51. Johnson & Johnson Revenue Growth Rate in EPO Biomarkers Business (2017-2022)
    Figure 52. Merck Revenue Growth Rate in EPO Biomarkers Business (2017-2022)
    Figure 53. LG Life Sciences India Revenue Growth Rate in EPO Biomarkers Business (2017-2022)
    Figure 54. Amgen Revenue Growth Rate in EPO Biomarkers Business (2017-2022)
    Figure 55. Roche Revenue Growth Rate in EPO Biomarkers Business (2017-2022)
    Figure 56. Agilent Revenue Growth Rate in EPO Biomarkers Business (2017-2022)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Siemens
Thermo Fisher Scientific
Pfizer
Novartis
Johnson & Johnson
Merck
LG Life Sciences India
Amgen
Roche
Agilent
Frequently Asked Questions
EPO Biomarkers report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
EPO Biomarkers report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
EPO Biomarkers report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Fertility Drug

Fertility Drug market is segmented by players, region (country), by Type and by Application. Play ... Read More

Freeze Drying

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More